CUAMC
OCUL icon

China Universal Asset Management Company’s Ocular Therapeutix OCUL Stock Holding History

China Universal Asset Management Company’s Portfolio OCUL Stock Details OCUL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$342K Sell
34,848
-3,783
-10% -$34.3K 0.02% 300
2026
Q1 		$327K Buy
38,631
+2,915
+8% +$27.8K 0.02% 302
2025
Q4 		$434K Sell
35,716
-24,783
-41% -$301K 0.03% 270
2025
Q3 		$707K Sell
60,499
-1,496
-2% -$17.9K 0.06% 207
2025
Q2 		$575K Buy
61,995
+30,460
+97% +$238K 0.05% 231
2025
Q1 		$231K Sell
31,535
-1,801
-5% -$13.8K 0.02% 300
2024
Q4 		$285K Buy
33,336
+3,347
+11% +$32.7K 0.03% 299
2024
Q3 		$261K Buy
29,989
+11,793
+65% +$97.2K 0.03% 278
2024
Q2 		$124K Sell
18,196
-3,003
-14% -$18.5K 0.02% 285
2024
Q1 		$193K Buy
21,199
+12,007
+131% +$85.2K 0.02% 295
2023
Q4 		$41K Buy
9,192
+7,152
+351% +$21.1K 0.01% 387
2023
Q3 		$6.41K Buy
2,040
+1,024
+101% +$4.19K ﹤0.01% 375
2023
Q2 		$5.24K Sell
1,016
-27
-3% -$161 ﹤0.01% 365
2023
Q1 		$5.5K Buy
1,043
+261
+33% +$1.24K ﹤0.01% 357
2022
Q4 		$2.2K Buy
782
+61
+8% +$202 ﹤0.01% 367
2022
Q3 		$3K Buy
+721
New +$3.63K ﹤0.01% 329

Other funds holding OCUL

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Deep Track Capital
Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Avoro Capital Advisors
Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return
SR
Summer Road West Palm Beach, Florida $161M AUM 27.24% 1-Year Est. Return
VA
VR Adviser New York $3.3B AUM 525.74% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Logos Global Management
Logos Global Management San Francisco, California $2.32B AUM 536.01% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

China Universal Asset Management Company's OCUL Position: Q2 2026 in Review

China Universal Asset Management Company reduced its Ocular Therapeutix (OCUL) stake by 9.8% in Q2 2026, selling an estimated $34.3K and leaving 34,848 shares worth $342K. The position accounts for 0.02% of the portfolio, ranked #300.

China Universal Asset Management Company first reported a position in OCUL in Q3 2022 and has held it in 16 quarters since. The position peaked at $707K in Q3 2025. 262 funds tracked by Wall St. Rank hold OCUL as of Q2 2026.

  • China Universal Asset Management Company held 34,848 shares of Ocular Therapeutix worth $342K as of Q2 2026.
  • China Universal Asset Management Company sold 3,783 Ocular Therapeutix shares in Q2 2026, an estimated $34.3K.
  • Ocular Therapeutix made up 0.02% of China Universal Asset Management Company's portfolio in Q2 2026, its #300 holding.
  • China Universal Asset Management Company first reported a position in Ocular Therapeutix in Q3 2022 and has held it in 16 quarters since.
  • China Universal Asset Management Company's Ocular Therapeutix position peaked at $707K in Q3 2025.
  • 262 funds tracked by Wall St. Rank held Ocular Therapeutix as of Q2 2026.

Based on China Universal Asset Management Company's 13F filing for Q2 2026, filed 24 Jul 2026.